vs
Side-by-side financial comparison of ASTRONICS CORP (ATRO) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $240.1M, roughly 1.4× ASTRONICS CORP). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $15.8M). Over the past eight quarters, ASTRONICS CORP's revenue compounded faster (13.9% CAGR vs 0.4%).
Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ATRO vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $240.1M | $339.0M |
| Net Profit | — | $44.7M |
| Gross Margin | 33.3% | 59.7% |
| Operating Margin | 14.8% | 19.9% |
| Net Margin | — | 13.2% |
| Revenue YoY | 15.1% | -2.7% |
| Net Profit YoY | — | 19.3% |
| EPS (diluted) | $0.82 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.1M | $339.0M | ||
| Q3 25 | $211.4M | $327.3M | ||
| Q2 25 | $204.7M | $321.4M | ||
| Q1 25 | $205.9M | $330.6M | ||
| Q4 24 | $208.5M | $348.5M | ||
| Q3 24 | $203.7M | $345.5M | ||
| Q2 24 | $198.1M | $336.2M | ||
| Q1 24 | $185.1M | — |
| Q4 25 | — | $44.7M | ||
| Q3 25 | $-11.1M | $38.7M | ||
| Q2 25 | $1.3M | $34.0M | ||
| Q1 25 | $9.5M | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $-11.7M | $33.8M | ||
| Q2 24 | $1.5M | $38.4M | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | 33.3% | 59.7% | ||
| Q3 25 | 30.5% | 59.5% | ||
| Q2 25 | 25.8% | 59.8% | ||
| Q1 25 | 29.5% | 58.4% | ||
| Q4 24 | 29.8% | 55.5% | ||
| Q3 24 | 27.1% | 54.2% | ||
| Q2 24 | 28.0% | 52.0% | ||
| Q1 24 | 25.7% | — |
| Q4 25 | 14.8% | 19.9% | ||
| Q3 25 | 10.9% | 17.9% | ||
| Q2 25 | 2.3% | 16.8% | ||
| Q1 25 | 6.4% | 21.6% | ||
| Q4 24 | 4.3% | 16.9% | ||
| Q3 24 | 4.1% | 15.0% | ||
| Q2 24 | 3.8% | 11.8% | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | 13.2% | ||
| Q3 25 | -5.2% | 11.8% | ||
| Q2 25 | 0.6% | 10.6% | ||
| Q1 25 | 4.6% | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -5.8% | 9.8% | ||
| Q2 24 | 0.8% | 11.4% | ||
| Q1 24 | -1.7% | — |
| Q4 25 | $0.82 | $0.95 | ||
| Q3 25 | $-0.31 | $0.81 | ||
| Q2 25 | $0.04 | $0.70 | ||
| Q1 25 | $0.26 | $1.17 | ||
| Q4 24 | $-0.07 | $0.74 | ||
| Q3 24 | $-0.34 | $0.66 | ||
| Q2 24 | $0.04 | $0.74 | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.2M | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $140.1M | $911.5M |
| Total Assets | $706.7M | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $363.4M | ||
| Q3 25 | $13.5M | $296.4M | ||
| Q2 25 | $13.5M | $292.9M | ||
| Q1 25 | $24.8M | $306.8M | ||
| Q4 24 | $9.3M | $320.8M | ||
| Q3 24 | $5.2M | $299.3M | ||
| Q2 24 | $2.9M | $344.4M | ||
| Q1 24 | $5.3M | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $140.1M | $911.5M | ||
| Q3 25 | $108.9M | $849.2M | ||
| Q2 25 | $271.6M | $882.3M | ||
| Q1 25 | $266.8M | $820.8M | ||
| Q4 24 | $256.1M | $906.9M | ||
| Q3 24 | $249.2M | $878.9M | ||
| Q2 24 | $257.9M | $905.4M | ||
| Q1 24 | $251.7M | — |
| Q4 25 | $706.7M | $2.5B | ||
| Q3 25 | $682.2M | $2.4B | ||
| Q2 25 | $646.7M | $2.5B | ||
| Q1 25 | $662.2M | $2.5B | ||
| Q4 24 | $648.8M | $2.5B | ||
| Q3 24 | $651.6M | $2.5B | ||
| Q2 24 | $644.9M | $2.5B | ||
| Q1 24 | $630.0M | — |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.6M | $93.6M |
| Free Cash FlowOCF − Capex | $15.8M | $87.2M |
| FCF MarginFCF / Revenue | 6.6% | 25.7% |
| Capex IntensityCapex / Revenue | 4.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | $93.6M | ||
| Q3 25 | $34.2M | $111.3M | ||
| Q2 25 | $-7.6M | $17.4M | ||
| Q1 25 | $20.6M | $116.6M | ||
| Q4 24 | $26.4M | $43.8M | ||
| Q3 24 | $8.4M | $48.8M | ||
| Q2 24 | $-6.3M | $-27.4M | ||
| Q1 24 | $2.0M | — |
| Q4 25 | $15.8M | $87.2M | ||
| Q3 25 | $21.0M | $106.3M | ||
| Q2 25 | $-12.2M | $13.6M | ||
| Q1 25 | $18.5M | $100.9M | ||
| Q4 24 | $23.2M | $35.2M | ||
| Q3 24 | $6.5M | $39.4M | ||
| Q2 24 | $-8.1M | $-33.1M | ||
| Q1 24 | $439.0K | — |
| Q4 25 | 6.6% | 25.7% | ||
| Q3 25 | 9.9% | 32.5% | ||
| Q2 25 | -6.0% | 4.2% | ||
| Q1 25 | 9.0% | 30.5% | ||
| Q4 24 | 11.1% | 10.1% | ||
| Q3 24 | 3.2% | 11.4% | ||
| Q2 24 | -4.1% | -9.8% | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 4.9% | 1.9% | ||
| Q3 25 | 6.2% | 1.5% | ||
| Q2 25 | 2.2% | 1.2% | ||
| Q1 25 | 1.0% | 4.7% | ||
| Q4 24 | 1.5% | 2.5% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 0.9% | 1.7% | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | -5.81× | 0.51× | ||
| Q1 25 | 2.17× | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | -4.08× | -0.71× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
